STOCK TITAN

Nkarta to Participate at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Nkarta, a biopharmaceutical company focused on engineered natural killer (NK) cell therapies for cancer, will present at three key investor conferences:

  • SVB Leerink 11th Annual Global Healthcare Conference on February 17, 2022, at 1:40 p.m. ET.
  • Cowen 42nd Annual Health Care Conference on March 7, 2022, at 10:30 a.m. ET.
  • Oppenheimer 32nd Annual Healthcare Conference on March 16, 2022, at 10:00 a.m. ET.

Webcasts of these presentations will be available on the company's website, with replays archived for approximately four weeks.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:

SVB Leerink 11th Annual Global Healthcare Conference
February 17, 2022
1:40 p.m. ET – fireside chat presentation

Cowen 42nd Annual Health Care Conference
March 7, 2022
10:30 a.m. ET – leukemias panel discussion

Oppenheimer 32nd Annual Healthcare Conference
March 16, 2022
10:00 a.m. ET – presentation

A simultaneous webcast of the presentations will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately four weeks.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer patients. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com


FAQ

What is Nkarta's participation in the SVB Leerink 11th Annual Global Healthcare Conference?

Nkarta will present at the SVB Leerink 11th Annual Global Healthcare Conference on February 17, 2022, at 1:40 p.m. ET.

When is Nkarta presenting at the Cowen 42nd Annual Health Care Conference?

Nkarta will present at the Cowen 42nd Annual Health Care Conference on March 7, 2022, at 10:30 a.m. ET.

What will Nkarta discuss at the Oppenheimer 32nd Annual Healthcare Conference?

Nkarta is scheduled for a presentation at the Oppenheimer 32nd Annual Healthcare Conference on March 16, 2022, at 10:00 a.m. ET.

Where can I watch Nkarta's conference presentations?

Nkarta's presentations will be webcast live and can be accessed on the Investors section of their website.

How long will Nkarta's conference presentation replays be available?

The replays of Nkarta's conference presentations will be archived on their website for approximately four weeks.

Nkarta, Inc.

NASDAQ:NKTX

NKTX Rankings

NKTX Latest News

NKTX Stock Data

176.07M
65.43M
4.87%
98.82%
13.56%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO